Brief: Bicycle Therapeutics To Present Trials In Progress Poster Featuring Bt7480 Phase I/Ii Clinical Trial At The 2022 Asco Annual Meeting
27/05/2022 24:43
May 26 (Reuters) - Bicycle Therapeutics PLC BCYC.O :
* BICYCLE THERAPEUTICS TO PRESENT TRIALS IN PROGRESS POSTER
FEATURING BT7480 PHASE I/II CLINICAL TRIAL AT THE 2022 ASCO
ANNUAL MEETING
Source text for Eikon: ID:nBw7nnR9Wa
Further company coverage: BCYC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bicycle Therapeutics
See all newsBicycle Therapeutics PLC reports results for the quarter ended September 30 - Earnings Summary
UK's Bicycle Therapeutics Q3 loss narrows as expenses fall
Bicycle Therapeutics PLC expected to post a loss of 43 cents a share - Earnings Preview
UK's Bicycle Therapeutics Q2 net loss narrows on reduced clinical program expenses
Bicycle Therapeutics Q1 revenue drops after partnership terminations